137 related articles for article (PubMed ID: 26825466)
1. Cadherins: The Superfamily Critically Involved in Breast Cancer.
Ashaie MA; Chowdhury EH
Curr Pharm Des; 2016; 22(5):616-38. PubMed ID: 26825466
[TBL] [Abstract][Full Text] [Related]
2. Nuclear factor I-C regulates E-cadherin via control of KLF4 in breast cancer.
Lee HK; Lee DS; Park JC
BMC Cancer; 2015 Mar; 15():113. PubMed ID: 25879941
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cadherins in cancer.
Breier G; Grosser M; Rezaei M
Cell Tissue Res; 2014 Mar; 355(3):523-7. PubMed ID: 24619142
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM
Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367
[TBL] [Abstract][Full Text] [Related]
5. ERalpha signaling through slug regulates E-cadherin and EMT.
Ye Y; Xiao Y; Wang W; Yearsley K; Gao JX; Shetuni B; Barsky SH
Oncogene; 2010 Mar; 29(10):1451-62. PubMed ID: 20101232
[TBL] [Abstract][Full Text] [Related]
6. Cadherins and epithelial-to-mesenchymal transition.
Gheldof A; Berx G
Prog Mol Biol Transl Sci; 2013; 116():317-36. PubMed ID: 23481201
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor entinostat reverses epithelial to mesenchymal transition of breast cancer cells by reversing the repression of E-cadherin.
Shah P; Gau Y; Sabnis G
Breast Cancer Res Treat; 2014 Jan; 143(1):99-111. PubMed ID: 24305977
[TBL] [Abstract][Full Text] [Related]
8. FOXA1 Induces E-Cadherin Expression at the Protein Level via Suppression of Slug in Epithelial Breast Cancer Cells.
Anzai E; Hirata K; Shibazaki M; Yamada C; Morii M; Honda T; Yamaguchi N; Yamaguchi N
Biol Pharm Bull; 2017; 40(9):1483-1489. PubMed ID: 28867731
[TBL] [Abstract][Full Text] [Related]
9. FOXA2 attenuates the epithelial to mesenchymal transition by regulating the transcription of E-cadherin and ZEB2 in human breast cancer.
Zhang Z; Yang C; Gao W; Chen T; Qian T; Hu J; Tan Y
Cancer Lett; 2015 Jun; 361(2):240-50. PubMed ID: 25779673
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of the epithelial mesenchymal transition factors Snail, Slug, Twist, TGF-β, and E-cadherin in ameloblastoma.
Kurioka K; Wato M; Iseki T; Tanaka A; Morita S
Med Mol Morphol; 2017 Jun; 50(2):68-75. PubMed ID: 27995335
[TBL] [Abstract][Full Text] [Related]
11. Defining the E-cadherin repressor interactome in epithelial-mesenchymal transition: the PMC42 model as a case study.
Hugo HJ; Kokkinos MI; Blick T; Ackland ML; Thompson EW; Newgreen DF
Cells Tissues Organs; 2011; 193(1-2):23-40. PubMed ID: 21051859
[TBL] [Abstract][Full Text] [Related]
12. Slug-upregulated miR-221 promotes breast cancer progression through suppressing E-cadherin expression.
Pan Y; Li J; Zhang Y; Wang N; Liang H; Liu Y; Zhang CY; Zen K; Gu H
Sci Rep; 2016 May; 6():25798. PubMed ID: 27174021
[TBL] [Abstract][Full Text] [Related]
13. Cadherins and catenins in breast cancer.
Cowin P; Rowlands TM; Hatsell SJ
Curr Opin Cell Biol; 2005 Oct; 17(5):499-508. PubMed ID: 16107313
[TBL] [Abstract][Full Text] [Related]
14. Oncofetal H19 RNA promotes tumor metastasis.
Matouk IJ; Raveh E; Abu-lail R; Mezan S; Gilon M; Gershtain E; Birman T; Gallula J; Schneider T; Barkali M; Richler C; Fellig Y; Sorin V; Hubert A; Hochberg A; Czerniak A
Biochim Biophys Acta; 2014 Jul; 1843(7):1414-26. PubMed ID: 24703882
[TBL] [Abstract][Full Text] [Related]
15. Altered expression of E-Cadherin-related transcription factors indicates partial epithelial-mesenchymal transition in aggressive meningiomas.
Wallesch M; Pachow D; Blücher C; Firsching R; Warnke JP; Braunsdorf WEK; Kirches E; Mawrin C
J Neurol Sci; 2017 Sep; 380():112-121. PubMed ID: 28870549
[TBL] [Abstract][Full Text] [Related]
16. Involvement of members of the cadherin superfamily in cancer.
Berx G; van Roy F
Cold Spring Harb Perspect Biol; 2009 Dec; 1(6):a003129. PubMed ID: 20457567
[TBL] [Abstract][Full Text] [Related]
17. Tumor-induced upregulation of Twist, Snail, and Slug represses the activity of the human VE-cadherin promoter.
Lopez D; Niu G; Huber P; Carter WB
Arch Biochem Biophys; 2009 Feb; 482(1-2):77-82. PubMed ID: 19046938
[TBL] [Abstract][Full Text] [Related]
18. EGF induces epithelial-mesenchymal transition through phospho-Smad2/3-Snail signaling pathway in breast cancer cells.
Kim J; Kong J; Chang H; Kim H; Kim A
Oncotarget; 2016 Dec; 7(51):85021-85032. PubMed ID: 27829223
[TBL] [Abstract][Full Text] [Related]
19. PARP3 controls TGFβ and ROS driven epithelial-to-mesenchymal transition and stemness by stimulating a TG2-Snail-E-cadherin axis.
Karicheva O; Rodriguez-Vargas JM; Wadier N; Martin-Hernandez K; Vauchelles R; Magroun N; Tissier A; Schreiber V; Dantzer F
Oncotarget; 2016 Sep; 7(39):64109-64123. PubMed ID: 27579892
[TBL] [Abstract][Full Text] [Related]
20. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]